About: Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.70 (-0.42%)
QNRX NASDAQ Quoin Pharmaceuticals Ltd DRC
Quoin Pharmaceuticals Ltd DRC share price
QNRX price activity
Last Price
$4.700
Change (24hr)
-0.02 USD (-0.42%)
Volume
25.95K
Volume (4w avg)
-
Open
$4.61
Day Range
$4.50 - $4.83
Previous Close
$4.72
Last Trade
07 Oct, 8:05 pm GMT+0
Delayed
07 Oct, 8:05 pm GMT+0
QNRX price performance
Delayed
07 Oct, 8:05 pm GMT+0
QNRX Market Signals